|Over a week ago|
Convey Holding Parent initiated with a Neutral at JPMorgan » 08:1907/1207/12/21
JPMorgan analyst Anne…
JPMorgan analyst Anne Samuel initiated coverage of Convey Holding Parent with a Neutral rating and $12 price target. The analyst views Convey as a play on the growing Medicare Advantage market with profitable growth. The analyst says that while the industry backdrop is favorable, the company's growth is expected to come largely from the existing customer base versus new wins. The customer concentration keeps Samuel at Neutral.
Convey Holding Parent initiated with a Buy at Canaccord » 07:2407/1207/12/21
Canaccord analyst Richard…
Canaccord analyst Richard Close initiated coverage of Convey Holding Parent with a Buy rating and $18 price target. Convey looks uniquely positioned for sustained profitable growth for many years to come, Close tells investors in a research note. There remains plenty of runway for cross-sell growth within its 162 clients that Close believes can support 15%+ growth in revenue and 20%+ in adjusted EBITDA long term, the analyst adds.
Convey Holding Parent initiated with a Buy at Truist » 07:1707/1207/12/21
Truist analyst Sandy…
Truist analyst Sandy Draper initiated coverage of Convey Holding Parent with a Buy rating and $16 price target. Convey's business is multifaceted with a tech-enabled solutions business as well as an advisory business which complement one another to maximize value for the company's clients, Draper tells investors in a research note. Its business model is sticky, with high visibility and strong EBITDA margins, the analyst adds.
Convey initiated with a Buy at BofA » 06:4207/1207/12/21
BofA analyst Michael…
BofA analyst Michael Cherny initiated coverage of Convey Holding Parent, the holding company of Convey Health, with a Buy rating and $15 price target. Convey provides back office technology platforms and additional value-added services designed to ease the administrative burden of healthcare payers and the opportunity for upsell within its existing base remains significant, Cherny tells investors.
Convey Holding Parent initiated with an Overweight at Barclays » 05:2807/1207/12/21
Barclays analyst Steve…
Barclays analyst Steve Valiquette initiated coverage of Convey Holding Parent with an Overweight rating and $16 price target. Convey is a healthcare technology company that specializes in offering products and services to government sponsored health plans, Valiquette tells investors in a research note. He believes the company Convey has a "unique opportunity to up-sell and cross-sell to existing clients."
Convey Health initiated with a Buy at Goldman Sachs » 19:4307/1107/11/21
Goldman Sachs analyst…
Goldman Sachs analyst George Tong initiated coverage of Convey Health with a Buy rating and $21 price target. The analyst believes Convey Health's technology and services platform purpose-built for government-sponsored health plans confers a wide competitive moat capable of sustaining robust 15%-plus average annual organic revenue growth, with growth tailwinds from a large addressable market, MA member growth, rising supplemental benefits utilization and cross-selling. Tong expects margin expansion from mix to drive 20%-plus average annual EBITDA growth and a positive multiple re-rating.
|Over a month ago|
Opening Day: WalkMe stock price falls following $287M IPO » 08:3406/1906/19/21
CYT, FEMY, AMAM, DNAY, TRMR, ATAI, IPSC, RERE, VERV, LYEL, ISPC, WKME, MOLN, CNVY, ALZN, FLYW, PAY, ZIP, DAWN, FIGS, OMIC, CNTA, DIDI, QNIU, RGCB, ELEV, CMSL, DNUT, YOU, GS, MS, JPM, AMZN, F, SAFO, HOOD
Backed by Insight Venture…
Convey Health opens at $14, IPO priced at $14 » 10:2306/1606/16/21
Convey Health (CNVY)…
Convey Health (CNVY) priced 13.333M shares at $14.00. The deal priced at the low end of the $14.00-$16.00 range. BofA, Goldman Sachs and JPMorgan acted as joint book running managers for the offering. Convey Health is a specialized healthcare technology and services company that offers administrative solutions for government-sponsored health plans to "optimize member interactions, ensure compliance, and support end-to-end Medicare processes."
Convey Holding 13.333M share IPO priced at $14.00 » 19:4406/1506/15/21
The deal priced at low…
The deal priced at low end of $14.00-$16.00 range. BofA, Goldman Sachs and JPMorgan are acting as joint book running managers for the offering.
Convey Health Solutions announces launch of initial public offering » 15:2306/0706/07/21
Convey Health announced…
Convey Health announced it has launched the roadshow for the initial public offering of 13.33M shares of its common stock, with 11.67M shares to be offered by the company and 1.67M shares to be offered by a selling stockholder pursuant to a registration statement filed on Form S-1 with the SEC. The price range for the initial public offering is currently estimated to be between $14.00-$16.00 per share. The company has applied to list its common stock on the New York Stock Exchange under the ticker symbol "CNVY." The company intends to use the net proceeds that it receives from the proposed offering to repay amounts outstanding under its existing indebtedness and for general corporate purposes. The company will not receive any proceeds from the sale of shares of common stock by the selling stockholder. BofA Securities, Goldman Sachs, and J.P. Morgan are acting as lead book-runners and representatives of the underwriters for the offering, with Barclays acting as a joint book-runner. TPG Capital BD and Truist Securities are also acting as joint book-runners for the offering, and Canaccord Genuity is acting as joint lead manager. AmeriVet Securities and Siebert Williams Shank are acting as co-managers for the offering.